Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Cancer|September 7, 2002
Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxelMark A Socinski, Michael J Schell, Kamal Bakri, et al.
British Journal of Cancer|March 19, 2019
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistanceBen C Creelan, Jhanelle E Gray, Tawee Tanvetyanon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and OutcomeMichael J Schell, Mingli Yang, Edoardo Missiaglia, et al.
Molecular and Cellular Neurosciences|July 6, 2005
Muscarinic acetylcholine receptor activation enhances hippocampal neuron excitability and potentiates synaptically evoked Ca(2+) signals via phosphatidylinositol 4,5-bisphosphate depletionKenneth W Young, Daniela Billups, Carl P Nelson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2019
Completion of adjuvant therapy in patients with resected pancreatic cancerDanielle K DePeralta, Takuya Ogami, Jun-Min Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2012
A phase II study of RO4929097 in metastatic colorectal cancerJonathan R Strosberg, Timothy Yeatman, Jill Weber, et al.
Cancers|November 13, 2021
<i>APC</i> and <i>TP53</i> Mutations Predict Cetuximab Sensitivity across Consensus Molecular SubtypesRamya Thota, Mingli Yang, Lance Pflieger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2024
Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal CancerBrittney L Dickey, Ryan M Putney, Michael J Schell, et al.
BMC Cancer|March 11, 2022
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapyMingli Yang, Thomas B Davis, Lance Pflieger, et al.
Cancer Epidemiology|November 12, 2025
Nutritional intake of ω-3 fatty acid intake and clinical grade of prostate cancerNagi B Kumar, Saira Bahl, Daniel Lemay, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Cancer|September 7, 2002
Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxelMark A Socinski, Michael J Schell, Kamal Bakri, et al.
British Journal of Cancer|March 19, 2019
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistanceBen C Creelan, Jhanelle E Gray, Tawee Tanvetyanon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and OutcomeMichael J Schell, Mingli Yang, Edoardo Missiaglia, et al.
Molecular and Cellular Neurosciences|July 6, 2005
Muscarinic acetylcholine receptor activation enhances hippocampal neuron excitability and potentiates synaptically evoked Ca(2+) signals via phosphatidylinositol 4,5-bisphosphate depletionKenneth W Young, Daniela Billups, Carl P Nelson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2019
Completion of adjuvant therapy in patients with resected pancreatic cancerDanielle K DePeralta, Takuya Ogami, Jun-Min Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2012
A phase II study of RO4929097 in metastatic colorectal cancerJonathan R Strosberg, Timothy Yeatman, Jill Weber, et al.
Cancers|November 13, 2021
<i>APC</i> and <i>TP53</i> Mutations Predict Cetuximab Sensitivity across Consensus Molecular SubtypesRamya Thota, Mingli Yang, Lance Pflieger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2024
Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal CancerBrittney L Dickey, Ryan M Putney, Michael J Schell, et al.
BMC Cancer|March 11, 2022
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapyMingli Yang, Thomas B Davis, Lance Pflieger, et al.
Cancer Epidemiology|November 12, 2025
Nutritional intake of ω-3 fatty acid intake and clinical grade of prostate cancerNagi B Kumar, Saira Bahl, Daniel Lemay, et al.
Pageof 16